$LAES SEC Filings

Filed On	Filing
16 Oct 2026	REPORT OF FOREIGN PRIVATE ISSUER
16 Oct 2026	REPORT OF FOREIGN PRIVATE ISSUER
14 Oct 2026	FORM 425
14 Oct 2026	REPORT OF FOREIGN PRIVATE ISSUER
07 Oct 2026	Form 4: Enguent Jean-Pierre, Vice President, R&DSS Received 35,000 shares by exercise or conversion ($350) · Granted 50,000 Employee Stock Option Plan (right to buy) · Sold 35,000 shares ($85.9K)
06 Oct 2026	Form 4: Fergusson David Alexander, Director Granted 17,487 Employee Stock Option Plan (right to buy)
06 Oct 2026	Form 4: Pellaton Eric Adrien, Director Granted 24,810 Employee Stock Option Plan (right to buy)
06 Oct 2026	Form 4: Ward Peter, Director Granted 8,268 Employee Stock Option Plan (right to buy)
02 Oct 2026	REPORT OF FOREIGN PRIVATE ISSUER
25 Sep 2026	REPORT OF FOREIGN PRIVATE ISSUER
25 Sep 2026	REPORT OF FOREIGN PRIVATE ISSUER
14 Sep 2026	REPORT OF FOREIGN PRIVATE ISSUER
11 Sep 2026	REPORT OF FOREIGN PRIVATE ISSUER
03 Sep 2026	Form 4: Enguent Jean-Pierre, Vice President, R&DSS Received 15,000 shares by exercise or conversion ($150) · Sold 15,000 shares ($36K)
26 Aug 2026	REPORT OF FOREIGN PRIVATE ISSUER
26 Aug 2026	Form 3: Hirsch Alexander Sebastian, Chief Marketing Officer No securities owned
18 Aug 2026	REPORT OF FOREIGN PRIVATE ISSUER
17 Aug 2026	Form 3: Brau Daniel Frederic Alexandre, Chief Quantum Officer No securities owned
14 Aug 2026	REPORT OF FOREIGN PRIVATE ISSUER
14 Aug 2026	REPORT OF FOREIGN PRIVATE ISSUER

Comments